Leidos Gets Patent for Peptide-Class of Checkpoint Inhibitors

Leidos’ life sciences unit has secured a U.S. patent for its new peptide-based PD-1 checkpoint inhibitors developed for more targeted delivery of treatments.

The company said Thursday that the U.S. Patent and Trademark Office issued the patent for Leidos Health Life Sciences through the Patents 4 Patients program.

The program provides a faster review process for cancer immunotherapy-related patent applications.

Gabriel Gutierrez, Leidos researcher and one of the developers, said the team utilized tools used to fight cancer to develop the checkpoint inhibitors to fight infectious diseases such as malaria and HIV.

“Peptides represented an ideal tool to achieve our goal and this patent represents an important milestone for us,” he said.

Leidos said peptides enable researchers to provide more targeted delivery of treatments as they serve as a therapeutic platform that can be genetically engineered into vaccines, oncolytic viruses and cellular therapies.

You may also be interested in...

Nimbix

Nimbix Unveils High-Performance Computing Offerings for Gov’t Customers

Nimbix has announced availability of its high-performance computing services to support cloud platforms compliant with the Federal Risk and Authorization Management Program, International Traffic in Arms Regulations and other government-imposed security standards. The company said Tuesday its JARVICE XE and HyperHub platforms offer HPC for artificial intelligence and simulation uses in defense, aerospace, energy and health care industries.

Tutor Perini

Tutor Perini Subsidiary Awarded $67M for Defense, Homeland Security Infrastructure Projects

A Tutor Perini subsidiary has booked $66.9 million in two awards for construction efforts with the departments of Defense and Homeland Security. Perini Management Services Inc. will renovate U.S. Air Force Academy's Cadet Field House in Colorado and design and build a dormitory at the Glynco campus for DHS.

Intelligent Artifacts

Intelligent Artifacts to Launch R&D on Sensor Fusion Tech for USAF

New York-based artificial intelligence company Intelligent Artifacts has secured a contract of an undisclosed sum through the first phase of the Small Business Innovation Research program to explore and develop a sensor fusion technology for the U.S. Air Force.